Project Grant HT94252310745
Award Date
8/1/23
Completion Date
7/31/27
Dollars Obligated
$471K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Salt Lake City, UT 84112, USA
Similar Awards
This Project Grant award of $1,539,469.00 from the Defense Health Agency was provided to the University of Utah under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the "Molecular Crosstalk Between Estrogens and Progestogens in Endometrial Cancer." The award will fund this biomedical research project from September 1, 2023 to August 31, 2026. The University of Utah has an extensive track record of collaborating with government agencies on...
The Defense Health Agency awarded a $2,185,825.00 Project Grant to The University of Iowa for the project "PROGESTIN THERAPY FOR ENDOMETRIAL CANCER" under the "Military Medical Research and Development" program (CFDA 12.420). The grant, effective August 1, 2023 through July 31, 2027, will support research to study the effects of progestins on the normal mouse mammary gland. The University of Kansas Medical Center Research Institute, Inc. is a sub-grantee providing expertise...
The University of Utah has been awarded a $824,512 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from June 1, 2024 to May 31, 2027, will fund research on "Digital Pathology Predictions of Treatment Response in Hormone-Sensitive Prostate Cancer." This project aims to leverage digital pathology techniques to improve the prediction of treatment outcomes for patients with hormone-sensitive...
The University of Utah has been awarded a $654,105 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Digital Pathology Predictions of Treatment Response in Hormone-Sensitive Prostate Cancer." The three-year grant, awarded on June 1, 2024, will support the university's cutting-edge research aimed at improving health outcomes for military service members, veterans, and the broader public. The...
The Defense Health Agency awarded a $592,228 Project Grant to the University of Utah under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Understanding the Interplay of Aspirin and Other Commonly Used Medication and the Potential for Ovarian Cancer Chemoprevention." The three-year grant, awarded September 15, 2023 and concluding September 14, 2026, will support the University of Utah's research into medical solutions for ovarian cancer...
The University of Utah has been awarded a $1,128,787 Project Grant by the Defense Health Agency, an agency of the U.S. Department of Defense, under the Military Medical Research and Development program (CFDA 12.420). The grant is for a 3-year project titled "OPTIMIZING QUANTITATIVE PHASE IMAGING FOR PREDICTING BREAST CANCER THERAPY RESPONSE," with a performance period from January 15, 2024 to January 14, 2027. The funded research aims to develop and evaluate advanced quantitative phase...
This federal Project Grant award, valued at $538,998.00 and provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), aims to enhance the antitumor myeloid immune response for the treatment of adrenocortical carcinoma. The award was made to the University of Utah's Office of Sponsored Projects Division, a major recipient of federal funding that conducts cutting-edge biomedical research. The funding will support a research project focused...
The University of Utah has been awarded a $1,232,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "TARGETING IRON-SULFUR CLUSTER ASSEMBLY A NOVEL VULNERABILITY IN KIDNEY CANCER," will fund research focused on developing new treatment approaches for kidney cancer. The award period runs from July 1, 2024, through June 30, 2028. This federal grant program supports a range of biomedical...
The University of Utah received a $1,385,985 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on September 1, 2024, will fund a research project focused on the "Impact of Multimodal Telerehabilitation on Reducing Disparities in Rural Survivors of Metastatic Prostate Cancer" through August 31, 2027. This project aims to investigate innovative approaches to improving...
The University of Utah will receive $6,079,790 under a four-year Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research from July 2022 to June 2026 to develop functional precision oncology approaches to predict, prevent, and treat early metastatic recurrence of triple-negative breast cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical...